Merger

Recorded: 2015-04-23 Pages: 5

Assignor

CORUS PHARMA, INC.

Executed: 2006-12-22

Assignee

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404

Covered Property (1)

Inhalable Aztreonam Lysinate Formulation for Treatment and Prevention of Pulmonary Bacterial Infections

Patent: 9,345,663 →

Application: 14/266,096 →

Publication: US 2014/0243304

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.